A voluntary recall of over 112,000 bottles of Amazon Private Label Extra Strength Acetaminophen has been initiated following reports of discoloured tablets. The recall, launched on September 18 by Aurobindo Pharma USA Inc., involves 112,932 bottles of 500-milligram caplets across multiple distribution channels.
At the time of writing, the US Food and Drug Administration (FDA) has not classified the health hazard level associated with this specific recall. The affected stock includes 14,640 bottles of 200-count, bearing lot number ACD125040A, with an expiration date of 30/09/2027.
Additionally, the recall covers 90,456 bottles of 500-count across various lots, including ACD124036A and ACD124030A expiring on 30/09/2027. Further affected 500-count lots include ACD124042A expiring on 31/10/2027, ACD124048B expiring on 30/11/2027, and ACD125010A expiring on 29/02/2028.
Furthermore, 7,836 bottles of 1,000-count under lot number ACD124048A, expiring on 30/11/2027, are also included in the nationwide recall. "Amazon is voluntarily recalling specific lots of Amazon Basic Care Extra Strength Pain Relief acetaminophen 500mg caplets due to reports of tablet discolouration," an Amazon spokesperson stated.
"This is a voluntary recall initiated in coordination with the manufacturer, Aurohealth, and the FDA to ensure consumer safety standards." Health authorities confirmed that no adverse health effects have been reported by consumers in connection with the use of these batches. Acetaminophen, widely known as Tylenol in the United States and paracetamol in other international regions, is a standard over-the-counter remedy for managing pain and reducing fever.